Article

Unraveling the Mystery of Changes to USP

The Pharmacy Compounding Accreditation Board, Attentus Medical Sales Inc, and VGM and Associates will host a series of free webinars to discuss the implications of the recently released hazardous drug safety standards by the United States Pharmacopeial Convention USP .

The Pharmacy Compounding Accreditation Board, Attentus Medical Sales Inc, and VGM and Associates will host a series of free webinars to discuss the implications of the recently released hazardous drug safety standards by the United States Pharmacopeial Convention USP <800>.

Related Videos
Heart with stethoscope | Image Credit: © DARIKA - stock.adobe.com
Senior Doctor is examining An Asian patient.
Healthcare, pharmacist and woman at counter with medicine or prescription drugs sales at drug store.
Image Credit: © Birdland - stock.adobe.com
Pharmacy, Advocacy, Opioid Awareness Month | Image Credit: pikselstock - stock.adobe.com
Pharmacists, Education, Advocacy, Opioid Awareness Month | Image Credit: Jacob Lund - stock.adobe.com
Pharmacist assists senior woman in buying medicine in pharmacy - Image credit: Drazen | stock.adobe.com
Related Content
Before the Big Event: AI-Enabled Remote Cardiac Monitoring Can Mitigate Stress-Related Cardiovascular Events
December 2nd 2024

Before the Big Event: AI-Enabled Remote Cardiac Monitoring Can Mitigate Stress-Related Cardiovascular Events

Stuart Long
Public Health Matters: Pharmacists as Frontline Health Providers: Collaborating for Better Patient Outcomes
November 21st 2024

Public Health Matters: Pharmacists as Frontline Health Providers: Collaborating for Better Patient Outcomes

Christina M. Madison, PharmD, FCCP, AAHIVP
PREP Act, COVID-19, Pandemic, Pharmacy, Immunization | Image Credit: ©dusanpetkovic1 | stock.adobe.com
December 2nd 2024

Looming PREP Act Expiration Could Impact Health Care Access for Rural Patients

Ashley Gallagher, Associate Editor
Public Health Matters podcast logo
September 19th 2024

Public Health Matters: The Difference Between Misinformation and Disinformation, and How Information Can Inform Evidence-Based Decisions

FDA Approval, Ustekinumab, Stelera, Crohn disease, Plaque Psoriasis, Psoriatic Arthritis | Image Credit: © Araki Illustrations | stock.adobe.com
Published: December 2nd 2024 | Updated: December 2nd 2024

FDA Approves Ustekinumab-kfce as Sixth Biosimilar to Stelara

Ashley Gallagher, Associate Editor
Familiarize Yourself With Updated Clinical Guidelines Recommendations for Restless Legs Syndrome
December 1st 2024

Familiarize Yourself With Updated Clinical Guidelines Recommendations for Restless Legs Syndrome

Kamila Dymala, PharmD, RPh, MBA, BCMTM, PACS